Showing results (4751-4760 of 5,717) with videos related to
Sort By:
Pageof 572
BMC Nephrology|October 30, 2019
Arg913Gln variation of SLC12A3 gene is associated with diabetic nephropathy in type 2 diabetes and Gitelman syndrome: a systematic reviewEduardo De la Cruz-Cano, Cristina Del C Jiménez-González, Vicente Morales-García, et al.BMC Nephrology|October 30, 2019
Albumin losses during hemodiafiltration: all dialyzers are not created equal - a case reportCharles Cuvelier, Michel Tintillier, Gabriela Migali, et al.BMC Nephrology|April 1, 2006
Progressive neurological disease induced by tacrolimus in a renal transplant recipient: case presentationMarjan Chegounchi, Michael G Hanna, Guy H NeildBMC Nephrology|March 16, 2006
Protective effect of EDTA preadministration on renal ischemiaChiara Foglieni, Alessandro Fulgenzi, Paolo Ticozzi, et al.BMC Nephrology|October 23, 2004
Active collaboration with primary care providers increases specialist referral in chronic renal diseaseAdrian Mondry, Ai-Ling Zhu, Marie Loh, et al.BMC Nephrology|October 7, 2004
Renal outcome in adults with renal insufficiency and irregular asymmetric kidneysGuy H Neild, Gill Thomson, Dorothea Nitsch, et al.BMC Nephrology|August 21, 2004
Dialysis Disequilibrium Syndrome: brain death following hemodialysis for metabolic acidosis and acute renal failure--a case reportSean M Bagshaw, Adam D Peets, Morad Hameed, et al.BMC Nephrology|June 16, 2005
Does treating obesity stabilize chronic kidney disease?Sujata Agnani, Vidula T Vachharajani, Rohit Gupta, et al.BMC Nephrology|October 28, 2022
Use of regional citrate anticoagulation with medium cut-off membrane: pilot reportMarija Malgaj Vrečko, Jernej Pajek, Jadranka Buturović-PonikvarBMC Nephrology|October 18, 2022
A disease progression model estimating the benefit of tolvaptan on time to end-stage renal disease for patients with rapidly progressing autosomal dominant polycystic kidney diseaseGregory Mader, Deirdre Mladsi, Myrlene Sanon, et al.Pageof 572